Current affairs 07 January 2025

India Achieved over 1000 km of Metro Network: 3rd Largest in the World.

• Covering over 1,000 km across 11 states and 23 cities, India's Metro reached 1000 km milestone to become 3rd largest in the world with the inauguration of Delhi Metro's phase IV.
• PM Modi inaugurated and laid the foundations for railway projects in J-K, Telangana, and Odisha.
• Key projects include the New Jammu Railway Division, Charlapalli Terminal Station, and Rithala-Narela-Kundli corridor.

India’s First Organic Fisheries Cluster Launched in Sikkim.

• Union Minister Rajiv Ranjan Singh launched India’s first organic fisheries cluster in Soreng, Sikkim, promoting sustainability under PMMSY.
• Organic fish farming will avoid harmful chemicals, tapping into global eco-conscious markets, with NABARD providing financial and technical support.
• Projects worth ₹50 crores for North-East states were also inaugurated in Guwahati.

UP Govt's New Export Policy to Boost State’s Share in Exports.

• Aims to raise UP's export share from 4.71% to 7.5% by targeting Rs 3 trillion in merchandise exports within 2–3 years.
• Offers incentives like marketing support, air freight subsidies, and international certification for sectors like food processing and handicrafts.
• Focuses on creating export hubs, enhancing infrastructure, and promoting industries like Banarasi silk and Kanpur leather.

Lok Sabha Speaker Om Birla Launched "Panchayat Se Parliament 2.0".

• Om Birla inaugurated the Panchayat Se Parliament 2.0 program in New Delhi, with 500 elected women representatives from 20 states and UTs participating.
• The program focuses on empowering women from Scheduled Tribes in Panchayati Raj institutions through knowledge of governance and leadership.
• Women leaders aim to strengthen grassroots implementation of government schemes.

IIT-Guwahati Developed Injectable Hydrogel for Targeted Cancer Therapy.

• A water-based polymer network made from ultra-short peptides.
• Target Mechanism: Responds to elevated glutathione (GSH) levels in tumor cells.
• Localized Delivery: Ensures targeted drug release at tumor sites.
• Benefits: Reduces harm to healthy cells, offers prolonged therapeutic effects, and overcomes chemotherapy limitations with biocompatibility.